Spring direct naar de hoofdnavigatie of de inhoud
‘An adequate IP strategy protects innovation and creates new chances’
Marthe Lindenbergh

Marthe Lindenbergh

  • Life Sciences
  • Trainee Patent Attorney

Marthe Lindenbergh obtained a Bachelor’s and Master’s degree in Biomedical Sciences at Utrecht University. During the Master-phase, she did research internships in the UMC Utrecht and at the University of California, San Francisco. Having specialized in Infection and Immunity, she continued her studies with a PhD track at Utrecht University and the Wilhelmina Children’s Hospital, where she studied the immune-modulatory functions of immune-cell-derived extracellular vesicles. In 2019 she started as a trainee patent attorney at V.O. She obtained her PhD in November 2019.

Continue reading

Working experience

  • Trainee Patent Attorney V.O. (2019-present)
  • PhD University of Utrecht (2014-2018)

Education

  • PhD Infection and Immunity, University of Utrecht (2019)
  • MSc Infection and Immunity, University ofUtrecht (2014)
  • BSc Biomedical Sciences , University of Utrecht (2012)

Publications

  • M. Mues, L. Karra, D. Romero-Moya, A. Wandler, M. J. Hangauer, O. Ksionda, Y. Thus, M.F.S. Lindenbergh, K. Shannon, M. T. McManus, J. P. Roose. “High-complexity shRNA libraries and PI3 kinase inhibition in cancer: high-fidelity synthetic lethality predictions”. Cell Reports 2019
  • M.F.S. Lindenbergh, D.G.J. Koerhuis, E.G.F. Borg, E.M. van ’t Veld, T.A.P. Driedonks, R. Wubbolts, W. Stoorvogel, M. Boes. “Bystander T-cells support clonal T-cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles”. Front. Imm. 2019
  • M.F.S. Lindenbergh, W. Stoorvogel. “Antigen presentation by extracellular vesicles from professional antigen-presenting cells”.  Annu. Rev. Immunol. 2018
  • A.M. Gram, T. Oosenbrug, M.F.S. Lindenbergh, C. Büll, A. Comvalius, K.J.I. Dickson, J. Wiegant, H. Vrolijk, R.J. Lebbink, R. Wolterbeek, G.J. Adema, M. Griffioen, M.H.M. Heemskerk, D.C. Tscharke, L. M. Hutt-Fletcher, E.J.H.J. Wiertz, R.C. Hoeben, M.E. Ressing. “The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells”. PLoS Path. 2016
  • M. van Gent, A.M. Gram, I.G.J. Boer, R.J. Geerdink, M.F.S. Lindenbergh, R.J. Lebbink, E.J. Wiertz, M.E. Ressing. “Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion”.  J. Gen. Virol. 2015.

Languages

  • Dutch
  • English

Also see these experts

Hajo Kraak

Hajo Kraak

  • European and Dutch Patent Attorney
  • Partner
Bettina Hermann

Bettina Hermann

  • European and German Patent and Trademark Attorney
  • Partner
More experts

News

Put your hands together for the Nobel Prize in Chemistry 2021 – How fundamental research can lead to new opportunities in innovation

Last year the Nobel Prize in Chemistry goes to Benjamin List and David MacMillan for ‘the development of asymmetric organocatalysis’. This is a fine example of a fundamental scientific discovery that has quickly found a practical application.Continue reading

First meeting of the Administrative Committee of the new European Patent Court

On 22 February 2022, the first meeting of the Administrative Committee of the new European Patent Court (the Unified Patent Court) took place.Continue reading

Money Losing Party Court

V.O. model quickly estimates patent value

How do you estimate the economic value of a patent? V.O. has developed a model that arrives at an estimation based on various factors. This allows companies to have a better understanding of how much their patent can deliver for them.Continue reading

Events

Knowledge for Growth 2022

Gent ICC, Familie van Rysselberghedreef, Ghent, Belgium

The cream of the Belgian life sciences community attends flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, topnotch research institutes, policymakers and competence providers. Continue reading

Dutch Lifes Sciences Conference 2022

CORPUS Congress Centre, Willem Einthovenstraat, Oegstgeest, Netherlands

The foremost life sciences business network event in the Netherlands. Continue reading

Unitary Patent Package Conference 2022

Van der Valk Hotel Amsterdam - Amstel, Joan Muyskenweg, Amsterdam, Netherlands

Finally the Unitary Patent and the Unified Patent Court will become reality! In January 2022 Austria ratified as the 13th country and the new system will be up and running in the second half of 2022. So, patent professionals get prepared! Continue reading